Cover Image

The First Reported Japanese Case of PNPLA1‐Nonsyndromic Epidermal Differentiation Disorder (PNPLA1‐nEDD) Associated With an Unreported 92‐Base‐Pair Duplication Variant

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Shiori Kato, Takuya Takeichi, Keisuke Jojima, Maiko Kato, Michiya Omi, Kana Tanahashi, Atsushi Otsuka, Yoshinao Muro, Akio Kihara, Masashi Akiyama
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Experimental Dermatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A case of pachyonychia congenita with a hotspot variant at Arg127 in KRT16: Disease severity assessment using AlphaMissense technology
by: Tatsuhiro Noda, et al.
Published: (2024)

Second‐hit somatic variant in a basal cell carcinoma of a basal cell nevus syndrome patient with a germline SUFU variant
by: Tatsuhiro Noda, et al.
Published: (2025)

Mutation Analysis in Ten Cases With PNPLA1 ‐Nonsyndromic Epidermal Differentiation Disorder: Evidence of a Founder Effect
by: Yunran Peng, et al.
Published: (2026)

Cutaneous inflammation with upregulated interleukin‐36γ and TNFα in a patient with loricrin keratoderma
by: Takuya Maki, et al.
Published: (2025)

Comparing the severity of epidermolysis bullosa simplex harboring KRT5 variants with the AlphaMissense score
by: Michiya Omi, et al.
Published: (2024)

A Case of DPP ‐4 Inhibitor‐Associated Bullous Pemphigoid With Anti‐ LAD ‐1 IgG Antibodies Arising From a Post‐Traumatic Scar
by: Momoko Sasamoto, et al.
Published: (2025)

A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability
by: Ryo Fukaura, et al.
Published: (2024)

PNPLA3 variation and kidney disease
by: Alessandro Mantovani, et al.
Published: (2024)

A Cross‐Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career
by: Yuika Suzuki, et al.
Published: (2025)

Integrating PNPLA3 into clinical risk prediction
by: Vincent L. Chen, et al.
Published: (2024)

PNPLA3 in Alcohol‐Related Liver Disease
by: Clélia Galvanin, et al.
Published: (2024)

Experimental Models to Investigate PNPLA3 in Liver Steatosis
by: Alireza Ramandi, et al.
Published: (2025)

Immune‐Mediated Necrotizing Myopathy Overlapping With Anti‐ RuvBL1 /2 Antibody‐Positive Systemic Sclerosis
by: Rikako Isobe, et al.
Published: (2025)

Predictive Value of Anti‐ SMN Complex Antibodies for Monitoring Cardiopulmonary Complications in MCTD : Insights From an ELISA Study Using Recombinant Gemin4 and an Anti‐Nuclear Antibody Test
by: Haruka Koizumi, et al.
Published: (2025)

Sex‐specific effects of PNPLA3 I148M
by: Alessandro Cherubini, et al.
Published: (2024)

Alopecia universalis and type 1 diabetes mellitus both successfully controlled with baricitinib in a patient with autoimmune polyglandular syndrome type 3A
by: Ayane Goto, et al.
Published: (2025)

Fifteen Years of PNPLA3 : Transforming Hepatology Through Human Genetics
by: Stefano Romeo, et al.
Published: (2025)

Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk
by: Maria Castanho Martins, et al.
Published: (2024)

Targeting PNPLA3 to Treat MASH and MASH Related Fibrosis and Cirrhosis
by: Daniel Lindén, et al.
Published: (2024)

Impact of PNPLA3 Genotype on Hepatic Steatosis Response to Pemafibrate in MASLD With Dyslipidemia
by: Takao Shirono, et al.
Published: (2025)

Global Epidemiological Impact of PNPLA3 I148M on Liver Disease
by: Julia Kozlitina, et al.
Published: (2024)

Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD
by: Salvatore Petta, et al.
Published: (2024)

Paraspinal Muscle Atrophy on Chest CT as a Prognostic Marker for Anti‐Aminoacyl‐ tRNA Synthetase Antibody‐Positive Myositis
by: Norika Akashi, et al.
Published: (2026)

A Case of Rituximab Successfully Controlling SSc Vascular and Other Symptoms in a Pregnant Patient, Leading to a Safe Pregnancy and Delivery
by: Norika Akashi, et al.
Published: (2025)

Anti‐Ki/ SL Antibody‐Positive Deep Morphea Patient Also Positive for Anti‐ PL ‐12 and Anti‐Ro60 Antibodies
by: Ikumi Hattori, et al.
Published: (2025)

Cutaneous Lesions and Lung Squamous Cell Carcinoma Both Successfully Controlled With Chemoradiotherapy in a Patient With Cancer‐Associated Clinically Amyopathic Dermatomyositis With Anti‐Nuclear Matrix Protein 2 Antibodies
by: Arisu Sakai, et al.
Published: (2026)

PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease
by: Elizabeth K. Speliotes, et al.
Published: (2024)

Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans
by: Hannele Yki‐Järvinen, et al.
Published: (2025)

Formation of an optically thick shocked shell in the very fast nova V1674 Herculis: the origin of superbrightness
by: Hachisu, Izumi, et al.
Published: (2025)

Association Between PNPLA3 Inhibition and Gout: A Drug Target Mendelian Randomization Study
by: Chen Wang, et al.
Published: (2025)

Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity
by: Rachel B. Schenker, et al.
Published: (2024)

Late‐Onset, Slowly Progressive Pure Cerebellar Ataxia Associated with a Homozygous Missense Variant in PNPLA6
by: Agustín Querejeta‐Coma, et al.
Published: (2025)

Generalized acrodermatitis continua of Hallopeau with an IL36RN variant successfully treated with bimekizumab
by: Takenori Yoshikawa, et al.
Published: (2024)

Updated mutational spectrum and genotype–phenotype correlations in ichthyosis patients with ABCA12 pathogenic variants
by: Tatsuhiro Noda, et al.
Published: (2024)

Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
by: Jae Yoon Jeon, et al.
Published: (2024)

PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort Study
by: Daniel Q. Huang, et al.
Published: (2026)

Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus
by: Natália Coelho Lavrado, et al.
Published: (2024)

Enfortumab Vedotin–Induced Toxic Epidermal Necrolysis in Metastatic Urothelial Carcinoma Complicated by Severe Gastrointestinal Bleeding
by: Aika Matsuyama, et al.
Published: (2025)

Impact of PNPLA3 I148M on Drug‐Induced Hepatocellular Liver Injury: A Systematic Review and Meta‐Analysis
by: Alexandra Gatzios, et al.
Published: (2025)

The Evaluation of PNPLA2, ATGL, and G0S2 Levels in Serum and PBMCs of the Newly Diagnosed and the Chronic Patients With Rheumatoid Arthritis
by: Masoomeh Gholizadeh, et al.
Published: (2025)